Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly

ISSN:
1432-2277
Keywords:
Liver transplantation ; leishmaniasis-Leishmaniasis ; liver transplantation-Splenomegaly ; liver transplantation ; leishmaniasis
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract Visceral leishmaniasis was observed in a 50-year-old female liver transplant recipient 1 year following transplantation. Signs of active infection were low-grade fever, pancytopenia, persistent splenomegaly, positive cultures for leishmania in liver and bone marrow biopsy specimens, and newly positive leishmania serology. Following sequential therapy with pentavalent antimony and amphotericin B, blood values improved massively, bone marrow cultures became negative, and leishmania serology decreased. Secondary prophylaxis with fluconazole was instituted and the patient remains without signs of active infection 1 year after successful therapy.
Type of Medium:
Electronic Resource
URL:
_version_ 1798295976385970176
autor Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
autorsonst Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
book_url http://dx.doi.org/10.1007/BF00336642
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM200043439
issn 1432-2277
journal_name Transplant international
materialart 1
notes Abstract Visceral leishmaniasis was observed in a 50-year-old female liver transplant recipient 1 year following transplantation. Signs of active infection were low-grade fever, pancytopenia, persistent splenomegaly, positive cultures for leishmania in liver and bone marrow biopsy specimens, and newly positive leishmania serology. Following sequential therapy with pentavalent antimony and amphotericin B, blood values improved massively, bone marrow cultures became negative, and leishmania serology decreased. Secondary prophylaxis with fluconazole was instituted and the patient remains without signs of active infection 1 year after successful therapy.
package_name Springer
publikationsjahr_anzeige 1993
publikationsjahr_facette 1993
publikationsjahr_intervall 8009:1990-1994
publikationsjahr_sort 1993
publisher Springer
reference 6 (1993), S. 55-57
schlagwort Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
search_space articles
shingle_author_1 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
shingle_author_2 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
shingle_author_3 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
shingle_author_4 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
shingle_catch_all_1 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Abstract Visceral leishmaniasis was observed in a 50-year-old female liver transplant recipient 1 year following transplantation. Signs of active infection were low-grade fever, pancytopenia, persistent splenomegaly, positive cultures for leishmania in liver and bone marrow biopsy specimens, and newly positive leishmania serology. Following sequential therapy with pentavalent antimony and amphotericin B, blood values improved massively, bone marrow cultures became negative, and leishmania serology decreased. Secondary prophylaxis with fluconazole was instituted and the patient remains without signs of active infection 1 year after successful therapy.
1432-2277
14322277
Springer
shingle_catch_all_2 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Abstract Visceral leishmaniasis was observed in a 50-year-old female liver transplant recipient 1 year following transplantation. Signs of active infection were low-grade fever, pancytopenia, persistent splenomegaly, positive cultures for leishmania in liver and bone marrow biopsy specimens, and newly positive leishmania serology. Following sequential therapy with pentavalent antimony and amphotericin B, blood values improved massively, bone marrow cultures became negative, and leishmania serology decreased. Secondary prophylaxis with fluconazole was instituted and the patient remains without signs of active infection 1 year after successful therapy.
1432-2277
14322277
Springer
shingle_catch_all_3 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Abstract Visceral leishmaniasis was observed in a 50-year-old female liver transplant recipient 1 year following transplantation. Signs of active infection were low-grade fever, pancytopenia, persistent splenomegaly, positive cultures for leishmania in liver and bone marrow biopsy specimens, and newly positive leishmania serology. Following sequential therapy with pentavalent antimony and amphotericin B, blood values improved massively, bone marrow cultures became negative, and leishmania serology decreased. Secondary prophylaxis with fluconazole was instituted and the patient remains without signs of active infection 1 year after successful therapy.
1432-2277
14322277
Springer
shingle_catch_all_4 Horber, F. F.
Lerut, J. P.
Reichen, J.
Zimmermann, A.
Jaeger, P.
Malinverni, R.
Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Liver transplantation
leishmaniasis-Leishmaniasis
liver transplantation-Splenomegaly
liver transplantation
leishmaniasis
Abstract Visceral leishmaniasis was observed in a 50-year-old female liver transplant recipient 1 year following transplantation. Signs of active infection were low-grade fever, pancytopenia, persistent splenomegaly, positive cultures for leishmania in liver and bone marrow biopsy specimens, and newly positive leishmania serology. Following sequential therapy with pentavalent antimony and amphotericin B, blood values improved massively, bone marrow cultures became negative, and leishmania serology decreased. Secondary prophylaxis with fluconazole was instituted and the patient remains without signs of active infection 1 year after successful therapy.
1432-2277
14322277
Springer
shingle_title_1 Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
shingle_title_2 Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
shingle_title_3 Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
shingle_title_4 Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:44:42.704Z
titel Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
titel_suche Visceral leishmaniasis after orthotopic liver transplantation: impact of persistent splenomegaly
topic WW-YZ
uid nat_lic_papers_NLM200043439